Military service exposes personnel to environmental hazards that can have long-term impacts on lung health. Dust, smoke from burn pits, chemical agents, and high-intensity physical activity increase the risk of chronic respiratory disorders among veterans. Symptoms such as persistent cough, wheezing, shortness of breath, and reduced exercise tolerance often appear months or years after service, making diagnosis challenging. Evaluating these individuals requires detailed exposure histories, pulmonary function testing, imaging studies, and sometimes bronchoscopy to detect subtle airway inflammation or fibrotic changes. Early identification of military service–related lung disease is critical to prevent progression and reduce long-term complications, and preventive measures such as protective equipment and exposure monitoring can help mitigate risks during active duty.
Long-term care focuses on improving lung function, reducing symptoms, and preventing further deterioration. Pharmacologic therapies may include anti-inflammatory medications and bronchodilators tailored to individual patient needs. Pulmonary rehabilitation programs, physical conditioning, and lifestyle modifications such as smoking cessation are essential components of ongoing care. Structured follow-up enables early recognition of exacerbations and timely intervention, while multidisciplinary collaboration between pulmonologists, rehabilitation specialists, and veteran healthcare services ensures comprehensive support. Research into deployment-related exposures continues to inform clinical practice, preventive policies, and veteran health programs. Together, these strategies help optimize respiratory outcomes, support functional capacity, and enhance quality of life for affected military personnel.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation